Early cancer detection made possible through single-molecule precision.

By combining deep data science and advanced sequencing, Quantgene's QUANTUM ARRAY technology can identify multiple cancers down to the precision of a single molecule.

Which means cancer can be detected in its most early stage when treatment is more successful.


Today, regular routine cancer screening is not widely available. Therefore, most cancers are diagnosed at later stages- when they have already started to spread in the body and when chances of survival are far lower.

We believe patients deserve better.

Proactive cancer detection and routine screening is possible through new technology.

At Quantgene, our goal is to save lives by enabling the detection and treatment of cancer as early as possible. That’s why we are determined to bring the power of deep data science and advanced sequencing to the world of medicine.


Quantgene’s QUANTUM ARRAY, is the first fully-integrated technology stack that combines deep genomics and machine learning.

With one simple blood test, QUANTUM ARRAY executes rapid cfDNA sequencing to detect multiple forms of cancer down to a single molecule.


Detecting cancer is only the start. That’s why we are developing a whole solution for patients and physicians.

Quantgene is a comprehensive clinical framework informed by oncologists, medical experts, and primary care physicians. In the event of a positive test result, our team of experts provide clinical recommendations to help bring clarity to the next steps in diagnosis.